Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Dipyridamole and aspirin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dipyridamole 200mg modified-release / Aspirin 25mg capsules
0209000V0AAAAAA
|
Dipyridamole and aspirin | Dipyridamole and aspirin | Cardiovascular System | 15 |
|
Molita 200mg/25mg modified-release capsules
0209000V0BCAAAA
|
Molita | Dipyridamole and aspirin | Cardiovascular System | 1 |
|
Asasantin Retard capsules
0209000V0BBAAAA
|
Asasantin | Dipyridamole and aspirin | Cardiovascular System | No data available |
|
Atransipar 200mg/25mg modified-release capsules
0209000V0BDAAAA
|
Atransipar | Dipyridamole and aspirin | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.